The therapy group would take orally pancreatic kininogenase additionally for 8 weeks on the basis of original therapy schem and UAER before and after taking the medicine would be measured.

在原治疗基础上，治疗组加用口服胰腺激酞原酶8周，测定服药前后uaer的变化。